THERMO FISHER SCIENTIFIC INC. 8-K

What Happened

• Thermo Fisher Scientific, Inc. (TMO) announced its financial results for the fiscal quarter and year ended December 31, 2025 in a press release dated January 29, 2026. The press release is furnished as Exhibit 99.1 to the Form 8‑K.
• The Form 8‑K itself furnishes the earnings announcement and does not include the numeric results in-line; investors should consult Exhibit 99.1 (the press release) for detailed figures and metrics. The report states the furnished material is not "filed" under Section 18 of the Exchange Act.

Key Details

• Date of announcement: January 29, 2026.
• Period covered: quarter and fiscal year ended December 31, 2025.
• Press release provided as Exhibit 99.1 to the Form 8‑K (text incorporated by reference).
• Form 8‑K signed by Joseph R. Holmes, Vice President and Chief Accounting Officer.

Why It Matters

• This 8‑K signals Thermo Fisher has released its quarterly and full‑year earnings — a primary event that can affect the company’s stock price and investor decisions.
• Because the Form 8‑K furnishes the press release (rather than filing in a manner that is "filed" under Section 18), investors should read Exhibit 99.1 for revenue, earnings per share, segment results, and any forward guidance or management commentary.
• If you follow TMO for earnings, revenue, or guidance changes, review the attached press release and subsequent SEC filings (e.g., Form 10‑K or earnings presentation) for the complete financial details.